TroFuse-019
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
NeoImmuneTech
Alterome Therapeutics, Inc.
ToLymph Inc.
Hoffmann-La Roche
Nuvectis Pharma, Inc.
AstraZeneca
AstraZeneca
Avenzo Therapeutics, Inc.
Boehringer Ingelheim
AstraZeneca
Pheon Therapeutics
Pheon Therapeutics
Auricula Biosciences Inc.
DualityBio Inc.
Pfizer
Nuvation Bio Inc.
Tanabe Pharma America, Inc.
Adaptimmune
Novartis
AstraZeneca
TScan Therapeutics, Inc.
Iovance Biotherapeutics, Inc.
AstraZeneca
AstraZeneca
Sichuan Baili Pharmaceutical Co., Ltd.
Genelux Corporation
Travera Inc
Sanofi
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
AstraZeneca
Hoffmann-La Roche
Numab Therapeutics AG
Kiromic BioPharma Inc.
Intensity Therapeutics, Inc.
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Iovance Biotherapeutics, Inc.
Travera Inc
Simcha IL-18, Inc.
Advaxis, Inc.
R-Pharm
Evopoint Biosciences Inc.
Myeloid Therapeutics
Bristol-Myers Squibb
Multitude Therapeutics Inc.
Novartis
Kineta Inc.
Blueprint Medicines Corporation